September 20, 2020

The Niche

Knoepfler lab stem cell blog

Stemgenex

4 min read

More states have taken action against stem cell clinic-related firms in the past year than ever before and now we can add Georgia to the list. Georgia adds to growing list of state AGs suing stem cell clinics The George Attorney General Chris Carr filed suit against several related firms (going by various names over time) and their owner, Justin Paulk. The firms listed as defendants in addition to Paulk as an individual include, “Elite Integrated Medical, LLC, formerly known as Superior Healthcare of …Read More

5 min read

The FTC has sharply increased its oversight activities against stem cell and regenerative clinic firms. These new actions include quite a few warning letters. Here is the FTC database for COVID-19-related warning letters. Note that recently the FTC added a new, helpful option to view all of its warning letters here. It’s a good source of information. FTC warns many stem cell & related firms From USA Today, Brent Schrotenboer had this recent piece Stem cell companies sell hope with unproven medicine for COVID-19. Some …Read More

6 min read

Last year around this time I took my annual plunge to make 20 predictions for the coming year for the stem cell and regenerative medicine field. I even made a crystal ball graphic to highlight the complexity of the stem cell ecosystem into which these predictions were embedded (see image) for 2019. How’d I do? Below I grade my 20 predictions for this year. You can in addition see my grading of my 2018 predictions here. In the next week or so I’ll also …Read More

2 min read

How much money and how many patients do stem cell clinics like San Diego’s StemGenex make each year? A new court document has some insights from an unexpected angle. I’ve been following StemGenex for years here on The Niche. It’s been a rollercoaster ride. Things hit a new low today, perhaps marking the operational end of the company, but we’ll see. StemGenex has marketed non-FDA approved fat stem cells for a variety of health conditions. Their marketing is central to a patient class action …Read More